Form 4: Century Therapeutics SVP Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Douglas Carr, SVP of Finance & Operations at Century Therapeutics, sold shares to cover tax withholding obligations related to vesting restricted stock units.
Summary
- Douglas Carr, SVP Finance & Operations at Century Therapeutics, filed a Form 4 indicating changes in beneficial ownership.
- On November 1, 2024, 16,611 shares of common stock were disposed of to satisfy tax withholding obligations at a price of $1.26 per share.
- On November 4, 2024, 283 shares of common stock were sold at $1.227 per share to cover tax withholding obligations.
- Following these transactions, Carr beneficially owns 317,147 shares of Century Therapeutics common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to stock transactions by an officer. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of the US stock market and are required by the SEC to provide transparency into the transactions of company insiders.
Stakeholder Impact
- The stock sales may have a minor impact on shareholders due to the increased supply of shares in the market.
Key Dates
| Date | Description |
|---|---|
| 11/01/2024 | 16,611 shares disposed of to cover tax withholding obligations at $1.26 per share. |
| 11/04/2024 | 283 shares sold to cover tax withholding obligations at $1.227 per share. |
| 11/05/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.